Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.

PURPOSE: To compare the renal hemodynamic and tubular effects of celecoxib, a selective inhibitor of cyclooxygenase-2 (COX-2) to those of naproxen, a nonselective inhibitor of cyclooxygenases in salt-depleted subjects. METHODS AND SUBJECTS: Forty subjects were randomized into four parallel groups to receive 200 mg celecoxib twice a day, 400 mg celecoxib twice a day, 500 mg naproxen twice a day, or a placebo for 7 days according to a double-blind study design. Blood pressure, renal hemodynamics, and urinary water and electrolyte excretion were measured before and for 3 hours after drug intake on days 1 and 7. RESULTS: Celecoxib had no effect on systemic blood pressure, but short-term transient decreases in renal blood flow and glomerular filtration rate were found with the highest dose of 400 mg on day 1. On the first day, both celecoxib and naproxen decreased urine output (P < .05) and sodium, lithium, and potassium excretion (P < .01). On day 7, similar effects on water and sodium excretion were observed. During repeated administration, a significant sodium retention occurred during the first 3 days. CONCLUSION: In salt-depleted subjects, selective inhibition of COX-2 causes sodium and potassium retention. This suggests that an increased selectivity for COX-2 does not spare the kidney, at least during salt depletion.

Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects

Enjeu : L'incidence d'insuffisance rénale terminale augmente d'environ 5-6% par année dans nos régions. L'une des causes majeures d'insuffisance rénale est la néphropathie diabétique qui représente selon les pays entre 25 et 40% des néphropathies terminales. La progression de la néphropathie diabétique peut être ralentie de manière efficace par un bon contrôle du diabète et de l'hypertension artérielle et par le blocage du système rénine-angiotensine. Néanmoins, malgré l'application stricte de ces thérapies préventives, la néphropathie de bons nombres de patients diabétiques continue de progresser. Il est donc important de développer de nouvelles stratégies permettant de préserver la fonction rénale des patients diabétiques soit en améliorant le contrôle de la pression artérielle soit en diminuant la protéinurie. Contexte : Il existe un certain nombre d'évidences expérimentales que le blocage des récepteurs de l'endothéline pourrait avoir un effet positif sur le devenir de la néphropathie diabétique en diminuant de manière efficace la protéinurie même chez des animaux déjà traités efficacement avec un bloqueur du système rénine-angiotensine. Dans des études de phase 2 impliquant l'avosentan, un antagoniste des récepteurs de l'endothéline actuellement en cours de développement pour le traitement de la néphropathie diabétique, on a pu démontrer que cet antagoniste, prescrit à des doses oscillant entre 5 et 50 mg par jour per os, diminue la protéinurie d'environ 20-40% chez des patients déjà traités avec un IEC ou un antagoniste de l'angiotensine. Toutefois, une grande étude de phase III conduite avec ce médicament chez des patients diabétiques a du être interrompue précocement en raison de l'apparition d'oedèmes et d'une surcharge hydrosodée conduisant dans certains cas à une décompensation cardiaque aiguë. La rétention hydrosodée est un effet secondaire connu des antagonistes de l'endothéline déjà sur le marché. Toutefois, pour l'avosentan, on ne savait pas si des doses plus faibles du médicament avaient aussi un effet négative sur la balance hydrosodée. En outre, les mécanismes rénaux responsables de la rétention hydrosodée sont encore mal connus chez l'homme. C'est pourquoi, nous avons organisé et réalisé cette étude de pharmacologie clinique chez le volontaire sain posant 2 questions : 1) des doses faibles d'avosentan produisent-elles aussi une rétention hydrosodée chez l'homme ? et 2) quels sont les mécanismes rénaux pouvant expliquer la rétention hydrosodée ? Cette thèse est donc une étude clinique de phase I testant chez 23 volontaires sains les effets rénaux de différentes doses d'avosentan ou d'un placebo pour établir la courbe dose-réponse des effets rénaux de ce médicament. L'idée était également de définir quelle dose est sure et bien tolérée pour être utilisée dans une nouvelle étude de phase II. L'avosentan a été administré par voie orale une fois par jour pendant 8 jours à des doses de 0.5, 1.5, 5 et 50 mg. Les effets rénaux hémodynamiques et tubulaires ont été étudiés chez chaque sujet lors de la première administration (jour 1) et après une semaine de traitement (jour 8). Le médicament a induit une prise de poids dose-dépendante déjà présente à 5 mg et maximale à 50 mg (+ 0.8 kg au jour 8). Nous n'avons pas mesuré d'impact de l'avosentan sur l'hémodynamique rénale ni sur les électrolytes plasmatiques. En revanche, nous avons constaté une diminution dose-dépendante de la fraction d'excrétion de sodium (jusqu'à -8.7% avec avosentan 50 mg). Cette diminution était en rapport avec une augmentation dose-dépendante de la réabsorption proximale de sodium. Nous avons également constaté une baisse de la pression artérielle aux doses élevées et une hémodilution marquée par une baisse de l'hématocrite suggérant une rétention hydrique à la plus haute dose. Nos résultats suggèrent donc que l'avosentan induit une rétention sodée rénale dose-dépendante expliquée avant tout par une rétention du sodium au niveau du tubule proximal. Cet effet n'est pas observé à des doses plus basses que 5 mg chez le volontaire sain, suggérant que ce médicament devrait être évalué pour son activité réno-protectrice à des doses inférieures ou égales à 5 mg par jour. La raison pour laquelle les hautes doses produisent plus de rétention sodée est peut être liée à une perte de sélectivité pour les sous-types (A et B) de récepteurs à l'endothéline lorsque l'on administre des doses plus élevées que 5 mg. Perspectives : Les résultats de ce travail de thèse ont donc permis de caractériser les propriétés rénales d'un nouvel antagoniste des récepteurs de l'endothéline chez l'homme. Ces résultats ont aussi permis de guider le développement futur de ce médicament vers des doses plus faibles avec l'espoir de garder les effets bénéfiques sur la protéinurie tout en améliorant le profil de tolérance du médicament par l'utilisation de doses plus faibles. ANGLAIS The endothelin receptor antagonist avosentan may cause fluid overload at doses of 25 and 50 mg, but the actual mechanisms of this effect are unclear. We conducted a placebo-controlled study in 23 healthy subjects to assess the renal effects of avosentan and the dose dependency of these effects. Oral avosentan was administered once daily for 8 days at doses of 0.5, 1.5, 5, and 50 mg. The drug induced a dose-dependent median increase in body weight, most pronounced at 50 mg (0.8 kg on day 8). Avosentan did not affect renal hemodynamics or plasma electrolytes. A dose-dependent median reduction in the fractional renal excretion of sodium was found (up to 8.7% at avosentan 50 mg); this reduction was paralleled by a dose-related increase in proximal sodium reabsorption. It is suggested that avosentan dose-dependently induces sodium retention by the kidney, mainly through proximal tubular effects. The potential clinical benefits of avosentan should therefore be investigated at doses of ≤ 5 mg.

TRATAMENTO DE EFLUENTES DE TANQUES DE PISCICULTURA APLICANDO A TECNOLOGIA DE ELETROCOAGULAÇÃO

Para a realização deste trabalho, foi utilizada a técnica da eletrocoagulação (EC) para o tratamento de efluente de piscicultura. Um reator de EC em escala de laboratório, com capacidade de 1,5 L foi montado, utilizando um conjunto de quatro placas de eletrodos de alumínio, um agitador mecânico de alto torque microprocessado, fios condutores com garras de jacaré e uma fonte de tensão com potência regulável. Os eletrodos foram arranjados dentro da célula eletrolítica de forma monopolar, em paralelo e a uma distância de 11 mm. O efluente utilizado neste estudo foi coletado em tanques de piscicultura do centro de criação de peixes do Departamento de Engenharia de Pesca da Universidade Federal do Ceará. Para a determinação da melhor condição de operação do reator, foi feito um planejamento experimental por intermédio do Software “Statgrafics”, definindo, as variáveis operacionais e os seus respetivos intervalos de variação (pH inicial de 4 a 8, condutividade de 1000 a 4000 μS cm-1, tempo de eletrolise de 15 a 35 min., agitação de 200 a 600 rpm e corrente de 1 a 2,5 A), que combinadas entre si totalizaram um total de 35 ensaios experimentais. Com base nos resultados obtidos por meio das análises físico-químicas em laboratório, pode-se afirmar que o pH inicial=8, condutividade=1000 μS cm-1, tempo=35 min., agitação=200 rpm e corrente=2,5 A, são as condições ótimas de operação do reator. Nestas condições, alcançaram remoção de 84,95% para DQO, 98,06% para nitrito, 82,43% para nitrato, 98,05% para fósforo total e 95,32% para a turbidez, sendo o custo operacional de 4,59 R$/m3 de efluente tratado. Com base nos resultados obtidos, pode-se concluir que alguns dos parâmetros analisados (pH, turbidez, temperatura, STD, nitrito, nitrato e fósforo total) estão de acordo com os padrões estabelecidos para água doce, classe 2, pela Resolução CONAMA nº 357/05, e de acordo com a Resolução CONAMA nº 430/2011 e a Portaria nº 154/2002 da SEMACE (CE), para lançamento do efluente final nos corpos receptores. A técnica de eletrocoagulação além de ser um método alternativo, eficiente e promissor para tratamento de efluentes de piscicultura, também mostrou ser ecologicamente correto por dispensar o consumo elevado de reagentes, ao contrário do que acontece no tratamento convencional.

Fanconi-Bickel syndrome and autosomal recessive proximal tubulopathy with hypercalciuria (ARPTH) are allelic variants caused by GLUT2 mutations.

CONTEXT: Many inherited disorders of calcium and phosphate homeostasis are unexplained at the molecular level. OBJECTIVE: The objective of the study was to identify the molecular basis of phosphate and calcium abnormalities in two unrelated, consanguineous families. PATIENTS: The affected members in family 1 presented with rickets due to profound urinary phosphate-wasting and hypophosphatemic rickets. In the previously reported family 2, patients presented with proximal renal tubulopathy and hypercalciuria yet normal or only mildly increased urinary phosphate excretion. METHODS: Genome-wide linkage scans and direct nucleotide sequence analyses of candidate genes were performed. Transport of glucose and phosphate by glucose transporter 2 (GLUT2) was assessed using Xenopus oocytes. Renal sodium-phosphate cotransporter 2a and 2c (Npt2a and Npt2c) expressions were evaluated in transgenically rescued Glut2-null mice (tgGlut2-/-). RESULTS: In both families, genetic mapping and sequence analysis of candidate genes led to the identification of two novel homozygous mutations (IVS4-2A>G and R124S, respectively) in GLUT2, the gene mutated in Fanconi-Bickel syndrome, a rare disease usually characterized by renal tubulopathy, impaired glucose homeostasis, and hepatomegaly. Xenopus oocytes expressing the [R124S]GLUT2 mutant showed a significant reduction in glucose transport, but neither wild-type nor mutant GLUT2 facilitated phosphate import or export; tgGlut2-/- mice demonstrated a profound reduction of Npt2c expression in the proximal renal tubules. CONCLUSIONS: Homozygous mutations in the facilitative glucose transporter GLUT2, which cause Fanconi-Bickel syndrome, can lead to very different clinical and biochemical findings that are not limited to mild proximal renal tubulopathy but can include significant hypercalciuria and highly variable degrees of urinary phosphate-wasting and hypophosphatemia, possibly because of the impaired proximal tubular expression of Npt2c.

Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.

This double-blind placebo-controlled study was designed to investigate the acute and sustained hormonal, renal hemodynamic, and tubular effects of concomitant ACE and neutral endopeptidase (NEP) inhibition by omapatrilat, a vasopeptidase inhibitor, in men. Thirty-two normotensive subjects were randomized to receive a placebo, omapatrilat (40 or 80 mg), or the fosinopril/hydrochlorothiazide (FOS/HCTZ; 20 and 12.5 mg, respectively) fixed combination for 1 week. Blood pressure, renal hemodynamics, urinary electrolytes and atrial natriuretic peptide excretion, and several components of the renin-angiotensin system were measured for 6 hours on days 1 and 7 of drug administration. When compared with the placebo and the FOS/HCTZ combination, omapatrilat induced a significant decrease in plasma angiotensin II levels (P<0.001 versus placebo; P<0.05 versus FOS/HCTZ) and an increase in urinary atrial natriuretic peptide excretion (P<0.01). These hormonal effects were associated with a significant fall in blood pressure (P<0.01) and a marked renal vasodilatation, but with no significant changes in glomerular filtration rate. The FOS/HCTZ markedly increased urinary sodium excretion (P<0.001). The acute natriuretic response to FOS/HCTZ was significantly greater than that observed with omapatrilat (P<0.01). Over 1 week, however, the cumulative sodium excretion induced by both doses of omapatrilat (P<0.01 versus placebo) was at least as great as that induced by the dose of FOS/HCTZ (P=NS versus FOS/HCTZ). In conclusion, the results of the present study in normal subjects demonstrate that omapatrilat has favorable renal hemodynamic effects. Omapatrilat combines potent ACE inhibition with a sustained natriuresis, which explains its well-documented potent antihypertensive efficacy.

First record of the behavior of latex drainage by Trigona spinipes (Fabricius) (Hymenoptera, Apidae) in laticiferous flowers

This paper describes the behavior of the bee Trigona spinipes, to avoid the latex, when piercing the base of the tubular corolla of the flowers of Mandevilla guanabarica in order to steal the nectar.

A new species of Sycorax Curtis, 1839 from Atlantic Forest in southeastern Brazil

A new species of Sycorax Curtis, 1839 (Diptera, Psychodidae) from the Atlantic Forest in southeastern Brazil. Sycorax bravoi Santos, Ferreira & Falqueto sp. nov. is described and illustrated based on samples collected with a Möricke trap installed on the ground at the Biological Station of Santa Lúcia, municipality of Santa Teresa, in the Brazilian state of Espírito Santo. Males have a paramere with a spiniform prolongation on the distal surface and an aedeagus with a long posterior membranous dorsal prolongation. Females have a racket-shaped genital furca and tubular spermatheca, tapered on the apical third. This finding raises the number of Sycorax species known from Brazil to seven.

cAMP-dependent chloride secretion mediates tubule enlargement and cyst formation by cultured mammalian collecting duct cells.

Polycystic kidney diseases result from disruption of the genetically defined program that controls the size and geometry of renal tubules. Cysts which frequently arise from the collecting duct (CD) result from cell proliferation and fluid secretion. From mCCD(cl1) cells, a differentiated mouse CD cell line, we isolated a clonal subpopulation (mCCD-N21) that retains morphogenetic capacity. When grown in three-dimensional gels, mCCD-N21 cells formed highly organized tubular structures consisting of a palisade of polarized epithelial cells surrounding a cylindrical lumen. Subsequent addition of cAMP-elevating agents (forskolin or cholera toxin) or of membrane-permeable cAMP analogs (CPT-cAMP) resulted in rapid and progressive dilatation of existing tubules, leading to the formation of cystlike structures. When grown on filters, mCCD-N21 cells exhibited a high transepithelial resistance as well as aldosterone- and/or vasopressin-induced amiloride-sensitive and -insensitive current. The latter was in part inhibited by Na(+)-K(+)-2Cl(-) cotransporter (bumetanide) and chloride channel (NPPB) inhibitors. Real-time PCR analysis confirmed the expression of NKCC1, the ubiquitous Na(+)-K(+)-2Cl(-) cotransporter and cystic fibrosis transmembrane regulator (CFTR) in mCCD-N21 cells. Tubule enlargement and cyst formation were prevented by inhibitors of Na(+)-K(+)-2Cl(-) cotransporters (bumetanide or ethacrynic acid) or CFTR (NPPB or CFTR inhibitor-172). These results further support the notion that cAMP signaling plays a key role in renal cyst formation, at least in part by promoting chloride-driven fluid secretion. This new in vitro model of tubule-to-cyst conversion affords a unique opportunity for investigating the molecular mechanisms that govern the architecture of epithelial tubes, as well as for dissecting the pathophysiological processes underlying cystic kidney diseases.

Male and female reproductive systems of Stolas conspersa (Germar) (Coleoptera, Chrysomelidae, Cassidinae)

Male and female reproductive systems of Stolas conspersa (Germar) (Coleoptera, Chrysomelidae, Cassidinae). The male and female reproductive systems of Stolas conspersa (Germar, 1824) are described and illustrated for the first time. The male reproductive system shows no difference from the subfamily pattern, which is a tubular well-developed median lobe; "Y", "V" or T-shaped tegmen; reduced pygidium; internal sac membranous and tubular; flagellum generally well developed needle-like structured and gastral spiculum absent. However, the female differs from the pattern proposed for Stolas in two aspects: ovary with 28 ovarioles and a reduced ampulla with indistinct velum.

Modelação cinética da conversão do furfural utilizando catalisadores multifuncionais

A utilização da biomassa como fonte de matéria-prima renovável para a obtenção de biocombustíveis e produtos de consumo pode reduzir os riscos geopolíticos e de segurança energética. As hemiceluloses – um dos principais componentes da biomassa vegetal - são convertidas industrialmente em furfural (Fur) que tem uma vasta gama de aplicações, sendo, por isso, considerado um dos compostos químicos renováveis de base mais importantes para biorefinarias. Este trabalho está relacionado com a valorização química do Fur, inserindo-se no conceito da Biorefinaria e nos objetivos de investigação do laboratório associado CICECO. Foi investigada a conversão catalítica do Fur em determinados bio-produtos de interesse para diversos setores da indústria química. Em particular, alquilfurfuril éteres, ésteres alquil-4-oxopentanoato, 5-metil-2-furanonas, ácido levulínico e gama-valerolactona são importantes para a produção de bio-aditivos para combustíveis, bio-polímeros, agroquímicos, aromas e fragrâncias, solventes, etc. A conversão do Fur nos bio-produtos envolve mecanismos reacionais complexos e requer o uso de catalisadores ácidos e de redução. A realização das múltiplas etapas num único reator é importante em termos de intensificação de processos. Neste trabalho, investigou-se a conversão do Fur em bio-produtos, num reator descontínuo fechado, a 120 ºC, utilizando catalisadores multifuncionais nanocristalinos do tipo zeólito beta contendo centros ativos de zircónio (Zr) e alumínio (Al). Com base numa revisão bibliográfica, propuseram-se dois modelos cinéticos pseudo-homogéneos para a conversão do Fur. Os modelos foram testados por ajuste das equações diferenciais ordinárias, representativas dos balanços às espécies reativas num reator descontínuo isotérmico, aos resultados experimentais de concentração versus tempo do Fur e cada um dos bio-produtos. Os estudos cinéticos foram combinados com os de caracterização dos catalisadores no estudo da influência das propriedades dos materiais nos diferentes passos do mecanismo global. Os centros ácidos de Al e Zr promoveram as reações ácidas e os de Zr eram essenciais para os passos de redução. No geral, as constantes cinéticas aparentes relativas às reações ácidas desejadas aumentaram com a razão Al/Zr dos catalisadores, e as dos passos de redução aumentaram com a diminuição da razão Si/Zr. O aumento da razão Al/Zr simultaneamente promoveu as reações indesejadas, diminuindo o rendimento total dos bio-produtos.

Aspectos reproductivos de Vinciguerria lucetia (Garman, 1899)

En el Perú, los estudios sobre peces mesopelágicos, fueron orientados hacia aspectos de taxonomía, distribución espacial y estimación acústica de la biomasa de Vinciguerria lucetia “vinciguerria”. Debido a su importancia tanto en el aspecto nutricional, económico como ecológico, la presente tesis pretende aportar una base científica para posteriores investigaciones, estableciendo una escala histológica de madurez gonadal que permita validar una escala macroscópica para facilitar el manejo de la obtención de datos sin tener que recurrir al uso de sofisticada maquinaria que actualmente es requerida para este tipo de investigación. El sistema reproductor de las hembras de V. lucetia consta de un par de ovarios, los cuales en su parte anterior están unidos por un solo oviducto y van adoptando una forma tubular en su parte media y posterior, terminando en bordes redondeados. Microscópicamente, los ovarios están conformados por una pared, lamelas y un estroma que los sostiene. El sistema reproductor de los machos consta de un par de testículos, de forma ligeramente laminar, con un túbulo de colección común que se engrosa en estadios maduros, microscópicamente, se diferenció una zona de crecimiento (periférica) y una zona de colección (central), en la primera se presentó los túbulos seminíferos y en la segunda los ductos eferentes. En el desarrollo ovocitario se caracterizó por presentar ovogonias y 5 tipos de ovocitos (inmaduro, pre-vitelogénico, vitelogénico, maduro e hidratado). Además de estructuras como folículos post – ovulatorios y atresia. El desarrollo espermatogénico presentó 4 tipos de células espermatogénicas (espermatogonia, espermatocito, espermátida y espermatozoide). La escala de madurez gonadal para hembras validada microscópicamente consta de 5 estadios (inmaduro, en maduración, maduro, desovante y recuperación) y macroscópicamente de 4 estadios (inmaduro, en maduración, maduro y desovante). Para machos, la escala macroscópica de madurez gonadal validada microscópicamente consta de 4 estadios (inmaduro, en maduración, maduro y expulsante). La proporción sexual de la fracción adulta fue favorable para hembras en el periodo de estudio y la talla de primera madurez gonadal para hembras a considerar es de 52 mm. El IGS promedio mostró un mayor valor para las hembras que para los machos, con un promedio de 5.19 ± 2.76 % y 4.38 ± 2.62 % respectivamente. El FC varió para las hembras de 0.20 - 0.87 %, con un promedio de 0.49 ± 0.09 % y para los machos de 0.28 - 0.87 %, con un promedio de 0.51 ± 0.09 %.

Marqueurs de la filtration glomérulaire en pédiatrie [Glomerular filtration markers in pediatrics]

The assessment of glomerular filtration rate (GFR) is critical for the diagnosis and management of renal diseases in pediatric nephrology. Ideally, it requires the measurement of the renal clearance of a filtration marker. Inulin, an exogenous marker, is the only compound the excretion of which occurs exclusively by glomerular filtration, with no tubular handling. Therefore, inulin clearance provides the most accurate method to measure GFR and is considered as the "gold standard", at all ages including very premature neonates. However, inulin dearance is cumbersome and alternative methods are used in clinical practice. If urine is available, endogenous creatinine clearance is the most reliable method. When urine collection is difficult to obtain, GFR can be estimated by the plasma concentration of endogenous markers mainly eliminated by glomerular filtration, such as creatinine, or the more recently described cystatin C and beta 2-microglobulin. When the endogenous production of these markers is constant, their plasma concentration reflects glomerular filtration; it increases with decreasing renal function. However, in pediatric patients creatinine production depends on muscle mass, which significantly increases with linear growth, as well as age and gender. Mathematical formulas taking these parameters into account have thus been developed. Among these, the so-called "Schwartz formula" is often used and is a reliable estimate of GFR in children. Finally, radionuclide renal scans can be used to evaluate the separate glomerular function of each kidney.

Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region.

BACKGROUND. Glomerular hyperfiltration (GHF) is a well-recognized early renal alteration in diabetic patients. As the prevalence of GHF is largely unknown in populations in the African region with respect to normal fasting glucose (NFG), impaired fasting glucose (IFG) and type 2 diabetes [diabetes mellitus (DM)], we conducted a cross-sectional study in the Seychelles islands among families including at least one member with hypertension. METHODS. The glomerular filtration rate (GFR), effective renal plasma flow (ERPF) and proximal tubular sodium reabsorption were measured using inulin, p-aminohippurate (PAH) and endogenous lithium clearance, respectively. Twenty-four-hour urine was collected on the preceding day. RESULTS. Of the 363 participants (mean age 44.7 years), 6.6% had IFG, 9.9% had DM and 63.3% had hypertension. The prevalence of GHF, defined as a GFR >140 ml/min, was 17.2%, 29.2% and 52.8% in NFG, IFG and DM, respectively (P trend <0.001). Compared to NFG, the adjusted odds ratio for GHF was 1.99 [95% confidence interval (CI) 0.73-5.44] for IFG and 5.88 (2.39-14.45) for DM. Lithium clearance and fractional excretion of lithium were lower in DM and IFG than NFG (P < 0.001). CONCLUSION. In this population of African descent, subjects with impaired fasting glucose or type 2 diabetes had a high prevalence of GHF and enhanced proximal sodium reabsorption. These findings provide further insight on the elevated incidence of nephropathy reported among African diabetic individuals.

Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.

The acute renal tubular effects of two pharmacologically distinct angiotensin II receptor antagonists have been evaluated in normotensive volunteers on various salt diets. In the first study, the renal response to a single oral dose of losartan (100 mg) was assessed in subjects on a low (50 mmol Na/d) and on a high (200 mmol Na/d) salt intake. In a second protocol, the renal effects of 50 mg irbesartan were investigated in subjects receiving a 100 mmol Na/d diet. Both angiotensin II antagonists induced a significant increase in urinary sodium excretion. With losartan, a modest, transient increase in urinary potassium and a significant increase in uric acid excretion were found. In contrast, no change in potassium and uric acid excretions were observed with irbesartan, suggesting that the effects of losartan on potassium and uric acid are due to the intrinsic pharmacologic properties of losartan rather than to the specific blockade of renal angiotensin II receptors. Assessment of segmental sodium reabsorption using lithium as a marker of proximal tubular reabsorption demonstrated a decreased distal reabsorption of sodium with both antagonists. A direct proximal tubular natriuretic effect of the angiotensin II antagonist could be demonstrated only with irbesartan. This apparent discrepancy allowed us to reveal the importance of acute water loading as a possible confounding factor in renal studies. The results of the present analysis show that acute water loading per se may enhance renal sodium excretion and hence modify the level of activity of the renin-angiotensin system expected from a given sodium diet. Since acute water loading is a common practice in clinical renal studies, this confounding factor should be taken into account when investigating the renal effects of vasoactive systems.

Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.

We investigated the short-term and sustained hormonal and renal effects of angiotensin II (Ang II) receptor blockade in normotensive healthy volunteers. Twenty-four subjects maintained on a fixed sodium diet were randomized to receive for 8 days a placebo or 10 or 50 mg doses of the Ang II antagonist irbesartan (SR 47436, BMS 186295) according to a double-blind, parallel group design. Plasma renin activity, plasma immunoreactive Ang II and aldosterone levels, blood pressure, renal hemodynamics, and urinary electrolyte excretion were measured for 8 hours after the first and eighth administration of each dose of irbesartan or placebo. Ang II receptor blockade with irbesartan induced a dose-dependent compensatory increase in plasma renin activity and plasma angiotensin levels and a significant decrease in plasma aldosterone levels. The compensatory rise in plasma renin activity and Ang II levels was more pronounced on day 8, reflecting a long duration of the blocking effect of irbesartan. Irbesartan induced small changes in blood pressure and did not significantly modify renal blood flow and glomerular filtration rate. However, a significant decrease in filtration fraction was observed during receptor blockade on days 1 and 8. The tubular effects of irbesartan were characterized by a dose-dependent increase in sodium and chloride excretions. Interestingly, the cumulative natriuretic response to Ang II receptor blockade was similar on days 1 and 8, suggesting that in these subjects, renal Ang II receptors are not blocked over 24 hours during repeated administration even though this antagonist has a long duration of action (t1/2 of 15 to 17 hours).(ABSTRACT TRUNCATED AT 250 WORDS)